Mass General Hospital

Harvard Medical School

Welcome to the MGH Center for Women’s Mental Health


Welcome to The Ammon-Pinizzotto Center for Women’s Mental Health at MGH. Our Center, established in 1989, has been renamed following the generous gift from Carol Ammon and Dr. Marie Pinizzotto. These resources will be used to realize the overarching mission of the Center.

This website provides a range of current information including discussion of new research findings in women’s mental health and how such investigations inform day-to-day clinical practice. Despite the growing number of studies being conducted in women’s health, the clinical implications of such work are frequently controversial, leaving patients with questions regarding the most appropriate path to follow. Providing these resources to patients and their doctors so that individual clinical decisions can be made in a thoughtful and collaborative fashion dovetails with the mission of our Center.

The National Pregnancy Registry for Psychiatric Medications:

All pregnant women ages 18-45 are eligible to enroll in the registry. We are currently seeking both controls and those being treated with atypical antipsychotics and/ or antidepressants.

This study will involve 3 brief phone interviews over an 8-month period. The National Pregnancy Registry for Psychiatric Medications is dedicated to evaluating the safety of psychiatric medications that may be taken by women during pregnancy to treat a wide range of mood, anxiety, or psychiatric disorders. The primary goal of this Registry is to determine the frequency of major malformations, such as heart defects, cleft lip, or neural tube defects, in infants exposed to atypical antipsychotics and antidepressants during pregnancy. For more information, please call 1-866-961-2388 or e-mail

Help make the future better for many other women like you.

The MGH Center for Women’s Mental Health

Perinatal and Reproductive Psychiatry Program

Simches Research Building

185 Cambridge St Suite 2200

Boston, MA 02114


To make an appointment:

Massachusetts General Hospital Clinical Program: (617) 724-7792

Location of appointments: 

Wang Ambulatory Care Center, Massachusetts General Hospital

15 Parkman St., Floor 8

Boston, MA 02114-3117 

Latest News from our Blog

  • Postpartum Depression: Focus on Managing Comorbid Anxiety Symptoms

    September 20, 2016


      Multiple studies have demonstrated the effectiveness of antidepressant medications for the treatment of postpartum depression (PPD).  Most of the these studies focused on the impact of these medications on depressive symptoms; however, it is clear that many, or maybe most, women with PPD also have significant anxiety symptoms.  Thus, we can hypothesize that medications which ...

    Read more
  • Weekly Roundup for SEP 17 2016: Recent Publications in Women’s Mental Health

    September 17, 2016


      Heading the list are two important reviews: one on postpartum psychosis from the American Journal of Psychiatry and another on the topic of perinatal suicide.  On the list, you will also find several interesting articles on the association between infertility treatment and postpartum depression (Tendais andFigueiredo, Gressier et al). Postpartum Psychosis: Madness, Mania, and Melancholia in ...

    Read more
  • Edinburgh Postnatal Depression Scale for Postpartum Depression: Three Items Better Than Ten

    September 13, 2016

    Credit: Depressed Mother from Wikimedia Commons

    The Edinburgh Postnatal Depression Scale (EPDS) is the screening instrument most commonly used to identify women with postpartum mood disorders.  This is a 10-item questionnaire which has been validated in many different populations and is available in almost every language. On this scale, a score of 10 or greater or an affirmative answer on question ...

    Read more
  • Taking a Look at the New FDA Pregnancy Labeling and Lactation Rule

    September 12, 2016


      The U.S. Food and Drug Administration (FDA) has proposed major revisions to prescription drug labeling in order to provide more accurate and helpful information on the effects of medications used during pregnancy and breastfeeding. The system used by the FDA for the last 30 years classifies the reproductive safety of medications using five risk categories ...

    Read more
  • Weekly Roundup for SEP 9 2016: Recent Publications in Women’s Mental Health

    September 9, 2016


    Lately we are seeing more articles about postpartum anxiety.  Although we typically emphasize postpartum depression, many women experience clinically significant symptoms of anxiety during pregnancy and the postpartum period.  This week we have one article from Goodman and colleagues focusing on postpartum anxiety and another from Biaggi et al which discusses anxiety during pregnancy. Anxiety disorders ...

    Read more
  • In Brief: CBT for Menopausal Sleep Problems Produces Lasting Effects

    August 29, 2016

    photo credit: Alarm via photopin (license)

      Peri- and postmenopausal women frequently complain of insomnia or poor sleep quality. Sleep disturbance is often attributed to nocturnal hot flashes; however, many menopausal women may have a primary sleep disorder, such as sleep apnea or restless leg syndrome. Various pharmacologic and nonpharmacologic options are available for the treatment of menopause-related insomnia.   The findings of a ...

    Read more

Read more from our Blog